CombinatoRx and Charley’s Fund/Nash Avery Foundation to Collaborate

CombinatoRx, Incorporated announced a research collaboration with Charley’s Fund and the Nash Avery Foundation, both nonprofit organizations founded to support Duchenne muscular dystrophy (DMD) research. The collaboration will seek to identify novel disease-modifying multi-targeted treatments for DMD, the most common form of muscular dystrophy.
Genetic Engineering & biotechnology News